L&C Bio shares plunge as ₩140.6 billion rights offering stokes dilution fears

The KOSDAQ-listed biotech plans to issue 3.7 million shares at a 26.8% discount, funding a Dongtan smart factory while weighing on the stock in early Tuesday trading.

NEAR

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.